Concepedia
Statistics
Publications
1
Citations
69
H-Index
Active since
2019
Karen Shepard is an author specializing in hepatocellular carcinoma pharmacotherapy, pharmacology, and liver disease.
Publications per year
2019–2019
A phase Ib trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) in unresectable hepatocellular carcinoma (uHCC): Updated results
Josep M. Llovet, Karen Shepard, RS Finn et al. · Annals of Oncology · 2019 · 69 citations · Full text
Medicine, Oncology, Pharmacology +13
1–1 of 1